1. Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis

   • Lucas Hendrik Overeem
   • Bianca Raffaelli
   • Uwe Reuter

   Systematic Review Open access 16 July 2021 Pages: 805 - 820

   

2. Exploring the Evidence for Broad-Spectrum Effectiveness of Perampanel: A Systematic Review of Clinical Data in Generalised Seizures

   • Eugen Trinka
   • Simona Lattanzi
   • Francesco Brigo

   Systematic Review Open access 07 July 2021 Pages: 821 - 837

   

3. Impact of CNS Stimulants for Attention-Deficit/Hyperactivity Disorder on Growth: Epidemiology and Approaches to Management in Children and Adolescents

   • Raman Baweja
   • Daniel E. Hale
   • James G. Waxmonsky

   Review Article 23 July 2021 Pages: 839 - 859

4. The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review

   • Marco Biolato
   • Assunta Bianco
   • Antonio Grieco

   Review Article Open access 28 July 2021 Pages: 861 - 880

5. Cardiovascular Effects of Combining Subcutaneous or Intravenous Esketamine and the MAO Inhibitor Tranylcypromine for the Treatment of Depression: A Retrospective Cohort Study

   • Vera M. Ludwig
   • Cathrin Sauer
   • Philipp Ritter

   Original Research Article Open access 20 July 2021 Pages: 881 - 892

   

6. Evidence-Based Expert Consensus Regarding Long-Acting Injectable Antipsychotics for Schizophrenia from the Taiwanese Society of Biological Psychiatry and Neuropsychopharmacology (TSBPN)

   • Kai-Chun Yang
   • Yin-To Liao
   • Ya-Mei Bai

   Original Research Article 27 July 2021 Pages: 893 - 905

7. Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study

   • Nabil Seery
   • Sifat Sharmin
   • Mastura Monif

   Original Research Article 13 April 2021 Pages: 907 - 918

8. Correction to: Effect of Enzyme‑Inducing Antiseizure Medications on the Risk of Sub‑Therapeutic Concentrations of Direct Oral Anticoagulants: A Retrospective Cohort Study

   • Amichai Perlman
   • Rachel Goldstein
   • Mordechai Muszkat

   Correction 03 August 2021 Pages: 919 - 919

9. Correction to: Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life‑Sustaining Therapies: A Systematic Review

   • Laurent M. Willems
   • Sebastian Bauer
   • Adam Strzelczyk

   Correction Open access 27 July 2021 Pages: 921 - 921

10. Correction to: Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis

    • Dee Lin
    • Philippe Thompson-Leduc
    • Patrick Lefebvre

    Correction 04 August 2021 Pages: 923 - 923